OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin on Food Reward and Aversion in Healthy Volunteers
Luke Tudge, Clare Williams, Philip J. Cowen, et al.
The International Journal of Neuropsychopharmacology (2015) Vol. 18, Iss. 6
Open Access | Times Cited: 53
Luke Tudge, Clare Williams, Philip J. Cowen, et al.
The International Journal of Neuropsychopharmacology (2015) Vol. 18, Iss. 6
Open Access | Times Cited: 53
Showing 26-50 of 53 citing articles:
Betel quid dependence is associated with functional connectivity changes of the anterior cingulate cortex: a resting-state fMRI study
Tao Liu, Jianjun Li, Zhongyan Zhao, et al.
Journal of Translational Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Tao Liu, Jianjun Li, Zhongyan Zhao, et al.
Journal of Translational Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
Jackson M. J. Oultram, Joseph L. Pegler, Tim Bowser, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 234-234
Open Access | Times Cited: 22
Jackson M. J. Oultram, Joseph L. Pegler, Tim Bowser, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 234-234
Open Access | Times Cited: 22
Cannabinoid type 1 receptor antagonism ameliorates harmaline‐induced essential tremor in rat
Hassan Abbassian, Benjamin J. Whalley, Vahid Sheibani, et al.
British Journal of Pharmacology (2016) Vol. 173, Iss. 22, pp. 3196-3207
Open Access | Times Cited: 24
Hassan Abbassian, Benjamin J. Whalley, Vahid Sheibani, et al.
British Journal of Pharmacology (2016) Vol. 173, Iss. 22, pp. 3196-3207
Open Access | Times Cited: 24
Tetrahydrocannabivarin is Not Tetrahydrocannabinol
Mehdi Haghdoost, Erica N. Peters, Matthew Roberts, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access | Times Cited: 2
Mehdi Haghdoost, Erica N. Peters, Matthew Roberts, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access | Times Cited: 2
A Two-Phase, Dose-Ranging, Placebo-Controlled Study of the Safety and Preliminary Test of Acute Effects of Oral Δ8-Tetrahydrocannabivarin in Healthy Participants
Erica N. Peters, Laura MacNair, Amy Harrison, et al.
Cannabis and Cannabinoid Research (2023) Vol. 8, Iss. S1, pp. S71-S82
Closed Access | Times Cited: 6
Erica N. Peters, Laura MacNair, Amy Harrison, et al.
Cannabis and Cannabinoid Research (2023) Vol. 8, Iss. S1, pp. S71-S82
Closed Access | Times Cited: 6
Structural and Functional Alterations in Betel-Quid Chewers: A Systematic Review of Neuroimaging Findings
Adellah Sariah, Zhening Liu, Weidan Pu, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 18
Adellah Sariah, Zhening Liu, Weidan Pu, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 18
Cannabinoids, Chemical Senses, and Regulation of Feeding Behavior
Ernesto Tarragón, Juan J. Moreno
Chemical Senses (2018) Vol. 44, Iss. 2, pp. 73-89
Open Access | Times Cited: 18
Ernesto Tarragón, Juan J. Moreno
Chemical Senses (2018) Vol. 44, Iss. 2, pp. 73-89
Open Access | Times Cited: 18
Awareness of dysgeusia and gustatory tests in patients undergoing chemotherapy for breast cancer
Sayaka Kuba, Rie Fujiyama, K. Yamanouchi, et al.
Supportive Care in Cancer (2018) Vol. 26, Iss. 11, pp. 3883-3889
Closed Access | Times Cited: 17
Sayaka Kuba, Rie Fujiyama, K. Yamanouchi, et al.
Supportive Care in Cancer (2018) Vol. 26, Iss. 11, pp. 3883-3889
Closed Access | Times Cited: 17
A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis
Lani Cupo, Eric Plitman, Elisa Guma, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Lani Cupo, Eric Plitman, Elisa Guma, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target
Eulla Keimili Fernandes Ferreira Cavalheiro, Ana Beatriz Costa, Daniéle Hendler Salla, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 2, pp. 135-151
Open Access | Times Cited: 13
Eulla Keimili Fernandes Ferreira Cavalheiro, Ana Beatriz Costa, Daniéle Hendler Salla, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 2, pp. 135-151
Open Access | Times Cited: 13
Screening Medications for the Treatment of Cannabis Use Disorder
L.V. Panlilio, Zuzana Justinová, José Trigo, et al.
International review of neurobiology (2016), pp. 87-120
Open Access | Times Cited: 14
L.V. Panlilio, Zuzana Justinová, José Trigo, et al.
International review of neurobiology (2016), pp. 87-120
Open Access | Times Cited: 14
An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models
Alex Straiker, Sierra Wilson, Wesley Corey, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5352-5352
Open Access | Times Cited: 11
Alex Straiker, Sierra Wilson, Wesley Corey, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5352-5352
Open Access | Times Cited: 11
Medical marijuana—an obesity problem or opportunity?
Frank L. Greenway, John P. Kirwan
International Journal of Obesity (2019) Vol. 43, Iss. 4, pp. 761-762
Open Access | Times Cited: 10
Frank L. Greenway, John P. Kirwan
International Journal of Obesity (2019) Vol. 43, Iss. 4, pp. 761-762
Open Access | Times Cited: 10
Anhedonia in chronic pain and prescription opioid misuse
Eric L. Garland, Martin Trøstheim, Marie Eikemo, et al.
(2019)
Open Access | Times Cited: 10
Eric L. Garland, Martin Trøstheim, Marie Eikemo, et al.
(2019)
Open Access | Times Cited: 10
Structure–Affinity Relationships and Structure–Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists
Lizi Xia, Henk de Vries, Eelke B. Lenselink, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 23, pp. 9545-9564
Open Access | Times Cited: 8
Lizi Xia, Henk de Vries, Eelke B. Lenselink, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 23, pp. 9545-9564
Open Access | Times Cited: 8
Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder
Erin L. Martin, Aimee L. McRae‐Clark
Current Addiction Reports (2020) Vol. 7, Iss. 4, pp. 545-552
Open Access | Times Cited: 7
Erin L. Martin, Aimee L. McRae‐Clark
Current Addiction Reports (2020) Vol. 7, Iss. 4, pp. 545-552
Open Access | Times Cited: 7
Ghrelin and Cannabinoid Functional Interactions Mediated by Ghrelin/CB1 Receptor Heteromers That Are Upregulated in the Striatum From Offspring of Mice Under a High-Fat Diet
Alejandro Lillo, Jaume Lillo, Iu Raïch, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 6
Alejandro Lillo, Jaume Lillo, Iu Raïch, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 6
New cannabinoid receptor antagonists as pharmacological tool
Pedro González-Naranjo, Concepción Pérez, Rocı́o Girón, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 19, pp. 115672-115672
Closed Access | Times Cited: 5
Pedro González-Naranjo, Concepción Pérez, Rocı́o Girón, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 19, pp. 115672-115672
Closed Access | Times Cited: 5
Medicinal Cannabis: an overview for health-care providers
Jason Wallach
Elsevier eBooks (2020), pp. 75-101
Closed Access | Times Cited: 5
Jason Wallach
Elsevier eBooks (2020), pp. 75-101
Closed Access | Times Cited: 5
Great Expectations: A Critical Review of and Recommendations for the study of Reward Processing as a Cause and Predictor of Depression
Dylan M. Nielson, Hanna Keren, Georgia O’Callaghan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4
Dylan M. Nielson, Hanna Keren, Georgia O’Callaghan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4
Differences in Brain Responses to Food or Tastants Delivered with and Without Swallowing: a Meta-analysis on Functional Magnetic Resonance Imaging (fMRI) Studies
Andy Wai Kan Yeung
Chemosensory Perception (2022) Vol. 15, Iss. 2, pp. 112-123
Closed Access | Times Cited: 3
Andy Wai Kan Yeung
Chemosensory Perception (2022) Vol. 15, Iss. 2, pp. 112-123
Closed Access | Times Cited: 3
Pharmacological actions and associated therapeutic levels of phytocannabinoids Addendum 2021
Jonathon C. Arnold, David Allsop, Nicholas Lintzeris, et al.
(2016)
Open Access | Times Cited: 1
Jonathon C. Arnold, David Allsop, Nicholas Lintzeris, et al.
(2016)
Open Access | Times Cited: 1
New ACMD regulations threaten UK's pharmaceutical discovery
David Nutt
The Lancet (2017) Vol. 389, Iss. 10086, pp. 2283-2283
Closed Access | Times Cited: 1
David Nutt
The Lancet (2017) Vol. 389, Iss. 10086, pp. 2283-2283
Closed Access | Times Cited: 1
The Functional Compounds of Cannabis sativa
Soheil Hajirahimkhan, Kathleen Hefferon, Nick Jackowetz
Elsevier eBooks (2023), pp. 51-59
Closed Access
Soheil Hajirahimkhan, Kathleen Hefferon, Nick Jackowetz
Elsevier eBooks (2023), pp. 51-59
Closed Access
